Related News
Home 禄 Business 禄 Manufacturing
Glaxo battles IRS over big tax burden
Source: Agencies |
May 25, 2009, Monday
|
Print Edition
Print Edition
BRITISH-BASED drug company GlaxoSmithKline is battling the United States Internal Revenue Service over a potential US$1.9 billion in back taxes, interest and penalties.
Glaxo had already detailed the dispute in its annual report in March, but the case was highlighted by The Wall Street Journal, which said the IRS was investigating a tax-savings technique employed by the company known as "earnings stripping."
The practice usually involves reducing taxable profits in the US by claiming excessive interest deductions on intercompany loans from units abroad.
Glaxo, the world's second-largest drug maker, said in the annual report that in this case the dispute arose over its "reclassification of an inter-company financing arrangement ... from debt to equity and its consequent recharacterization of the amounts paid as dividends subject to withholding tax."
Glaxo had already detailed the dispute in its annual report in March, but the case was highlighted by The Wall Street Journal, which said the IRS was investigating a tax-savings technique employed by the company known as "earnings stripping."
The practice usually involves reducing taxable profits in the US by claiming excessive interest deductions on intercompany loans from units abroad.
Glaxo, the world's second-largest drug maker, said in the annual report that in this case the dispute arose over its "reclassification of an inter-company financing arrangement ... from debt to equity and its consequent recharacterization of the amounts paid as dividends subject to withholding tax."
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 娌狪CP璇侊細娌狪CP澶05050403鍙-1
- |
- 浜掕仈缃戞柊闂讳俊鎭湇鍔¤鍙瘉锛31120180004
- |
- 缃戠粶瑙嗗惉璁稿彲璇侊細0909346
- |
- 骞挎挱鐢佃鑺傜洰鍒朵綔璁稿彲璇侊細娌瓧绗354鍙
- |
- 澧炲肩數淇′笟鍔＄粡钀ヨ鍙瘉锛氭勃B2-20120012
Copyright 漏 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
